Terveystalo (TTALO.HE) Stock Analysis & AI Equity Report

Health Care EUR Explore free reports

Terveystalo (TTALO.HE) overview

Terveystalo (TTALO.HE) stock analysis and AI equity research. For the latest completed financial year, 2025, Terveystalo reported revenue of EUR 1,279m and operating profit of EUR 138m; the year-end share price was 9.78 EUR and market capitalisation was EUR 1,239m. Terveystalo is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Terveystalo's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueEUR 584mFY 2025
Share price9.78 EURFY 2025 year end
RevenueEUR 1,279mFY 2025
Operating profitEUR 138mFY 2025
Net earningsEUR 92.6mFY 2025
Market capitalisationEUR 1,239mFY 2025 year end

Figures updated on 2026-07-27. Data will be refreshed during report generation.

About Terveystalo

Terveystalo is Finland's largest private healthcare services provider and one of the leading occupational health providers in Finland and Sweden. It offers primary care, specialist care, diagnostics, day surgery, rehabilitation and digital appointments to corporate, insurance, consumer and public-sector customers through clinics, hospitals and the Feelgood subsidiary in Sweden.

Generate the Terveystalo report

Terveystalo is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, typically within about 30 minutes

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Terveystalo and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Terveystalo

Each is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by what other analysts said the work added over the engine's report — a score out of five from people who had to read it to give it.